Rationale:
COVID-19 patients, especially immunocompromised or severely ill, have a higher probability of suffering from invasive fungal infections.
Patient concerns:
A 41-years-old male reported with pain and heaviness in the face for the past 20 days. Patient had tested COVID-19 positive 20 days back and was recently diagnosed with diabetes mellitus. On histopathological examination numerous hyphae resembling mucor and asper fungi were evident.
Diagnosis:
Chronic invasive aspergillosis with fulminant mucormycosis sparing palate.
Treatment:
Since the lesion was spreading very rapidly the patient was referred to an isolation facility for further management.
Outcomes:
We have postulated few hypothesis for the coinfection of aspergillosis and mucormycosis in our patient.
Take-away lessons:
It is important for the clinicians to systematically screen post COVID-19 patients for fungal infections, especially in immunocompromised and severely ill patients.